Results 131 to 140 of about 14,130 (212)

Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients [PDF]

open access: yes, 2000
Type 1 Gaucher disease (GD), the most prevalent lysosomal storage disease, results from the deficient activity of acid alpha-glucosidase. Molecular analysis of 12 unrelated Portuguese patients with type 1 GD identified three novel acid â-glucosidase ...
Amaral, O.   +4 more
core  

Case Report: Novel treatment approach for severe interstitial lung disease in type 3 Gaucher disease

open access: yesFrontiers in Pediatrics
Gaucher Disease Type 3 (GD3) is a rare lysosomal storage disorder characterized by both visceral and neurological involvement. Pulmonary manifestations can significantly impact prognosis and quality of life.
Vincenza Gragnaniello   +7 more
doaj   +1 more source

Rapid and long‐lasting efficacy of high‐dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review

open access: yesMolecular Genetics & Genomic Medicine
Gaucher disease (GD) is a lysosomal storage disorder caused by a deficiency in the GBA1‐encoded enzyme, β‐glucocerebrosidase. Enzyme replacement therapy is ineffective for neuronopathic Gaucher disease (nGD).
Kanako Higashi   +28 more
doaj   +1 more source

Gaucher disease: A 10 year old girl with anemia and huge spelenomegaly (a case report)

open access: yes, 2008
Gaucher's disease is a rare lipid storage disorder, affecting one in 40,000-200,000 people and results from a genetic deficiency of the enzyme glucocerebrosidase (glucosylceramidase).
Davarian, A., Mirbehbahani, N.B.
core   +1 more source

Effects of a Shortage of Imiglucerase on Three Patients with Type I Gaucher Disease [PDF]

open access: yes, 2011
Background: Children with Gaucher disease type I (GD1) are usually treated with enzyme replacement therapy (ERT) at a dose of 30-60U/Kg/2W. Recently, due to an acute shortage supply of imiglucerase, a reduced dose or a reduced infusion frequency was ...
Ferreira, AC, Sequeira, S
core  

A study of murine bone marrow cells cultured in bioreactors which create an environment which simulated microgravity [PDF]

open access: yes
Previous research indicated that mouse bone marrow cells could be grown in conditions of simulated microgravity. This environment was created in rotating bioreactor vessels. On three attempts mouse cells were grown successfully in the vessels.
Lawless, Brother Desales
core   +1 more source

Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers

open access: yesMolecular Neurobiology
Abstract One of the most common genetic risk factors for Parkinson’s disease (PD) is variants in GBA1 , which encodes the lysosomal enzyme glucocerebrosidase (GCase). GCase deficiency has been associated with an increased PD risk, but not all individuals with low GCase ...
Emma N. Somerville   +12 more
openaire   +3 more sources

Pleiotropic effects of variants in dementia genes in Parkinson disease [PDF]

open access: yes, 2018
Benitez, Bruno A   +11 more
core   +2 more sources

Glucocerebrosidase (GBA; GCase) [PDF]

open access: yesScience-Business eXchange, 2014
openaire   +1 more source

Glucocerebrosidase (GBA; GCase) [PDF]

open access: yesScience-Business eXchange, 2009
openaire   +1 more source

Home - About - Disclaimer - Privacy